Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
A Q&A With Paul Heidenreich, MD
A Q&A With Milton Packer, MD
A Q&A With Gary Besinque, PharmD
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
3
Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5
